Status:
COMPLETED
Urine Biomarker for Stone Recurrence
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Urolithiasis
Eligibility:
All Genders
18-100 years
Brief Summary
Despite the advent of treating stones with Extracorporeal Shock Wave Lithotripsy (ESWL) and Percutaneous nephrolithotomy (PCNL), the recurrence rate for renal stones remains high and this may be due t...
Detailed Description
Stone recurrences remain a major challenge in the management of renal stone patients, despite the emergence of ESWL as an internationally accepted method for the minimally invasive treatment of most r...
Eligibility Criteria
Inclusion
- Adult Chinese male patients with age \> 18 years old
- History of radio-opaque urinary calculi with treatment performed (including spontaneous passage) and now stone free.
Exclusion
- Patient refused or unable to provide consent for the study
Key Trial Info
Start Date :
July 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04354181
Start Date
July 24 2020
End Date
January 20 2023
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong